104 related articles for article (PubMed ID: 20606378)
1. Measurement and assessment of cytomegalovirus of immunoglobulin (Ig) g titer in preparations.
Shibaguchi H; Yamamoto T; Kuroki M; Futagami K
Yakugaku Zasshi; 2010 Jul; 130(7):977-82. PubMed ID: 20606378
[TBL] [Abstract][Full Text] [Related]
2. Comparison of cytomegalovirus (CMV)-specific neutralization capacity of hyperimmunoglobulin (HIG) versus standard intravenous immunoglobulin (IVIG) preparations: Impact of CMV IgG normalization.
Schampera MS; Schweinzer K; Abele H; Kagan KO; Klein R; Rettig I; Jahn G; Hamprecht K
J Clin Virol; 2017 May; 90():40-45. PubMed ID: 28342316
[TBL] [Abstract][Full Text] [Related]
3. Cytomegalovirus neutralization by hyperimmune and standard intravenous immunoglobulin preparations.
Planitzer CB; Saemann MD; Gajek H; Farcet MR; Kreil TR
Transplantation; 2011 Aug; 92(3):267-70. PubMed ID: 21659947
[TBL] [Abstract][Full Text] [Related]
4. Functional Properties of Human Cytomegalovirus Hyperimmunoglobulin and Standard Immunoglobulin Preparations.
Germer M; Herbener P; Schüttrumpf J
Ann Transplant; 2016 Sep; 21():558-64. PubMed ID: 27595792
[TBL] [Abstract][Full Text] [Related]
5. In vitro evaluation of cytomegalovirus-specific hyperimmune globulins vs. standard intravenous immunoglobulins.
Miescher SM; Huber TM; Kühne M; Lieby P; Snydman DR; Vensak JL; Berger M
Vox Sang; 2015 Jul; 109(1):71-8. PubMed ID: 25766313
[TBL] [Abstract][Full Text] [Related]
6. IgG subclass antibodies to human cytomegalovirus (CMV) in normal human plasma samples and immune globulins and their neutralizing activities.
Gupta CK; Leszczynski J; Gupta RK; Siber GR
Biologicals; 1996 Jun; 24(2):117-24. PubMed ID: 8889058
[TBL] [Abstract][Full Text] [Related]
7. A test for human cytomegalovirus-specific immunoglobulins using a modification of a commercial test kit.
Nath N; Fang C; Wunderlich C; Dodd RY; Tegtmeier G
J Virol Methods; 1987 Feb; 15(3):223-31. PubMed ID: 3031114
[TBL] [Abstract][Full Text] [Related]
8. Interaction of Immunoglobulin with Cytomegalovirus-Infected Cells.
Aiba N; Shiraki A; Yajima M; Oyama Y; Yoshida Y; Ohno A; Yamada H; Takemoto M; Daikoku T; Shiraki K
Viral Immunol; 2017 Sep; 30(7):500-507. PubMed ID: 28598267
[TBL] [Abstract][Full Text] [Related]
9. An enzyme immunoassay based micro-neutralization test for titration of antibodies to human cytomegalovirus (CMV) and its correlation with direct ELISA measuring CMV IgG antibodies.
Gupta CK; Leszczynski J; Gupta RK; Siber GR
Biologicals; 1996 Mar; 24(1):41-9. PubMed ID: 8733600
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of CMV ELISA antibody: titer and neutralizing activity in intramuscular immune globulin of placental origin.
Gibert R; el Habib R; Allard JP; Defayolle M; Aymard M
Transplant Proc; 1987 Oct; 19(5):4083-6. PubMed ID: 2823436
[TBL] [Abstract][Full Text] [Related]
11. Binding and neutralizing anti-cytomegalovirus activities in immune globulin products.
Wang X; Xu Y; Scott DE; Murata H; Struble EB
Biologicals; 2017 Nov; 50():35-41. PubMed ID: 29029807
[TBL] [Abstract][Full Text] [Related]
12. Functional differences between antiviral activities of sulfonated and intact intravenous immunoglobulin preparations toward varicella-zoster virus and cytomegalovirus.
Yajima M; Shiraki A; Daikoku T; Oyama Y; Yoshida Y; Shiraki K
J Infect Chemother; 2015 Jun; 21(6):427-33. PubMed ID: 25824903
[TBL] [Abstract][Full Text] [Related]
13. Serum concentrations of immunoglobulins and of antibody isotypes in bone marrow transplant recipients treated with high doses of polyspecific immunoglobulin or with cytomegalovirus hyperimmune globulin.
Gratwohl A; Doran JE; Bachmann P; Scherz R; Späth P; Baumgartner C; Perret B; Berger C; Nissen C; Tichelli A
Bone Marrow Transplant; 1991 Oct; 8(4):275-82. PubMed ID: 1661632
[TBL] [Abstract][Full Text] [Related]
14. Circulating cytomegalovirus (CMV) neutralizing activity in bone marrow transplant recipients: comparison of passive immunity in a randomized study of four intravenous IgG products administered to CMV-seronegative patients.
Filipovich AH; Peltier MH; Bechtel MK; Dirksen CL; Strauss SA; Englund JA
Blood; 1992 Nov; 80(10):2656-60. PubMed ID: 1330079
[TBL] [Abstract][Full Text] [Related]
15. Validation of an automated immunoglobulin G-only cytomegalovirus (CMV) antibody screening assay and an assessment of the risk of transfusion transmitted CMV from seronegative blood.
Seed CR; Piscitelli LM; Maine GT; Lazzarotto T; Doherty K; Stricker R; Stricker R; Iriarte B; Patel C
Transfusion; 2009 Jan; 49(1):134-45. PubMed ID: 18954407
[TBL] [Abstract][Full Text] [Related]
16. [CMV antibody determination with two enzyme immunoassays in each case].
Albert S; Sibrowski W; Kühnl P; Knödler B; Seidl S; Böhm BO; Doerr HW
Beitr Infusionsther; 1990; 26():40-2. PubMed ID: 1703884
[TBL] [Abstract][Full Text] [Related]
17. Immune monitoring of anti cytomegalovirus antibodies and risk of cytomegalovirus disease in heart transplantation.
Sarmiento E; Lanio N; Gallego A; Rodriguez-Molina J; Navarro J; Fernandez-Yañez J; Palomo J; Rodríguez-Hernández C; Ruiz M; Alonso R; Fernandez-Cruz E; Carbone J
Int Immunopharmacol; 2009 Jun; 9(6):649-52. PubMed ID: 18940269
[TBL] [Abstract][Full Text] [Related]
18. Detection of antibodies to cytomegalovirus by immunofluorescence and enzyme immunoassay.
Korcáková L; Kaslík J; Slízová I
Czech Med; 1990; 13(1):29-33. PubMed ID: 2161726
[TBL] [Abstract][Full Text] [Related]
19. Salivary immunoglobulins in recipients of bone marrow grafts. III. A longitudinal follow-up of CMV specific antibodies.
Chaushu G; Chaushu S; Slavin S; Or R; Garfunkel AA; Yefenof E
Bone Marrow Transplant; 1996 Feb; 17(2):237-41. PubMed ID: 8640173
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of immunoglobulin G preparations for anti-cytomegalovirus antibodies with reference to neutralizing antibody in the presence of complement.
Eizuru Y; Ueno I; Minamishima Y
J Clin Microbiol; 1988 Sep; 26(9):1881-3. PubMed ID: 2846652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
